The global Hematologic Malignancies Testing Market had a size of USD 2.55 billion in 2021 and is expected to grow at a CAGR of 14.7% during the forecast period. Hematologic malignancies are cancers that develop in blood, bone marrow, and lymph nodes. The rising prevalence of blood cancer, leukemia, and multiple myeloma worldwide, increasing healthcare spending, awareness among patients and...